Stem Cells in Translational Biomedicine – Information Page
SERIES EDITOR
Dr. Prasad S. Koka
Professor, Stem Cell Biology
Biomedical Research Institute of Southern California
Oceanside, California, USA
E-mail: scintbnova@gmail.com
Featured Scientific Article by Dr. Prasad S. Koka
“Biomarker Discovery and Biotherapeutics Applications of Photosynthetic Light-Harvesting and Bioluminescence Light-Emitting Chromophore-Protein Complexes in Stem Cell Biology and Regenerative Medicine”
This article is available via Open Access: “Biomarker Discovery and Biotherapeutics Applications of Photosynthetic Light-Harvesting and Bioluminescence Light-Emitting Chromophore-Protein Complexes in Stem Cell Biology and Regenerative Medicine”
EDITORIAL BOARD
Dr. Debamitra Das
Staff Scientist
Lieber Institute for Brain Development
Baltimore, Maryland, USA
E-mail: debamitradas@gmail.com
Dr. Connie J. Eaves
Terry Fox Laboratory
University of British Columbia
Vancouver, British Columbia, Canada
E-mail: ceaves@bccancer.bc.ca
Dr. P.V.G.K. Sarma
Head, Department of Biotechnology
Sri Venkateswara Institute of Medical Sciences and University
Tirupati, Andhra Pradesh, India
E-mail: pvgksarma@gmail.com
Dr. Inger Birgitta Sundell-Ranby
Department of Anthropology
Wayne State University
Detroit, Michigan, USA
E-mail: du2557@wayne.edu
Dr. Sarah E. Webb (Ho)
Division of Life Science
Hong Kong University of Science and Technology
Clear Water Bay, Kowloon, Hong Kong
E-mail: barnie@ust.hk
Dr. Jinyun Yuan
Washington University School of Medicine
St. Louis, Missouri, USA
NOTES FOR CONTRIBUTORS
Stem Cells in Translational Biomedicine is a peer-reviewed book series brought to you by the editors of Journal of Stem Cells. The book series is owned and operated by Nova Science Publishers and funded entirely by purchase orders and author-optional publication services. Each installment of the book series is available in print and electronic formats and sent to all the major index houses for evaluation.
Instructions for Reviewers
Reviewers who repeatedly decline to review manuscripts following their formal inclusion on the book series’ board will be removed from the list of reviewers at the Editor’s discretion.
Serving reviewers are advised to recommend their colleagues in the event they are unable to review the assigned manuscript.
Contributing authors can also recommend referees in their fields of expertise for reviewing their manuscripts if there is no conflict of interest.
Notes for Authors
There is no charge to submit your article and have it published in the series. Nova offers a number of optional publication services that carry fees, but authors are not required to select these services, and the services won’t be offered until after acceptance of the manuscripts. These services include Open Access, chapter offprints, discounted print copies of the book, and licenses for use of the published chapters.
Submission of a manuscript must be accompanied by a signed Copyright Transfer and Disclosure Form, which can be printed or downloaded here: https://novapublishers.com/wp-content/uploads/2021/09/CTDF-Copyright-Transfer-and-Disclosure-Form.pdf. Submissions that do not include a signed Copyright Transfer and Disclosure Form will be treated as incomplete.
Chapters should be submitted by email to the Editor listed below.
SERIES EDITOR
Dr. Prasad S. Koka
Professor, Stem Cell Biology
Biomedical Research Institute of Southern California
Oceanside, California, USA
E-mail: scintbnova@gmail.com
Authors will receive complimentary PDFs of their final chapters upon publication. Print copies of the books will be offered to authors at a discount.
Authors may deposit and display the accepted versions of their chapters in and on their personal non-commercial and affiliate non-commercial repositories and websites at any time. The same may be done with their final published chapters only after a period of one year has elapsed from the day of publication.
Peer-Review
Original or review chapters submitted to Stem Cells in Translational Biomedicine are sent for peer review to at least three reviewers. This number of reviewers can increase if some of the reviewers fail to respond, or if there is a conflict between the reviewers on the decision-making process by the Editor. If some of the reviewers’ comments are severely adverse in nature then the Editor will seek the response of additional reviewer(s). A final decision to accept or reject the manuscript is made by the Editor after seeking a suitable response from the authors to the reviewers’ comments. The revised version of the article may be sent back to the same reviewers before a decision is made. The authors’ responses and rebuttals on the reviewer(s) comments on the revised version of the manuscript will determine the decision of acceptance or rejection of the manuscript.
Manuscript Submissions
Before submitting your work, please read the complete notes and instructions below to ensure that you understand Nova’s manuscript requirements and publication procedures and that you are in compliance with the ethical standards rightfully set forth by Nova, the publishing industry, and the scientific community.
All abstracts and manuscripts must be written in English with references in standard Roman script.
It is understood that manuscripts submitted to the book series have not been submitted elsewhere for simultaneous publication consideration and have not been previously published, in whole or in part, unless the new manuscript is an expansion of the original, in which case full transparency of the re-used portions must be provided. Please note that manuscripts cannot be retracted or withdrawn after they have been published.
Manuscript Preparation
The book installments will include peer-reviewed original research and review articles, brief reports, rapid communications, mini- or short reviews, news items, book reviews, and letters to the Editor. Regular research manuscripts will consist of an abstract, introduction, materials and methods, results, discussion, acknowledgements, table and figure legends, and references.
The word count limitations for all submissions will be considered on case-by-case basis with importance to the delivery of the scientific information to the readers. Cover illustration of scientific significance from a contributing author might be considered by the Editor in consultation with the Publisher for a specific installment of the book series. The authors will submit to the Editor an electronic version of the manuscript, including cover letter, text, tables, figures, and illustrations as accepted for publication. The Editor reserves the right to reject publication of a manuscript that does not meet these requirements or in the Editor’s opinion is not original.
For final submission of publication, the manuscript text should be in MS Word.
In-text references should be either author-identified or reference-number-identified and placed in square brackets on the line, e.g., [37]. Examples of acceptable forms of reference lists at the end of the article are as follows:
Author, AB; Author, CD. Title of journal article. Title of journal, year of publication, volume number, first page-last page.
Publication Ethics
Nova is committed to maintaining trust in its publications, the value of authorship, and the integrity of science. Authors should be eager to help us maintain these standards. The following guidelines are provided to help authors avoid the appearance of ethical misconduct in their research and to help ensure adherence to the best practices set forth by national and international professional and regulatory bodies.
Plagiarism is a blight on the scientific community and a crime. The unauthorized use or close imitation of another’s language, text, data, ideas, or theories is prohibited. In all instances of authorized use, full credit to and representation of the original author’s work must be provided. It is the authors’ responsibility to secure permission for the use of copyrighted material. Nova uses software during the page proof stage of production to check for instances of plagiarism. Manuscripts will not be accepted for publication by the Publisher until Manuscripts are proven not to consist of plagiarized material. The Publisher will investigate all reports and suspicions of plagiarism. Authors suspected of plagiaristic misconduct will be contacted and given the opportunity to prove the validity of their work and refute the allegations. All instances of proven plagiarism will be reported to the Publisher by the editorial office, and the author’s institute, and other governing bodies will be contacted as necessary. Plagiarized Manuscripts already accepted for publication will be cancelled, and plagiarized articles that have already been published will be retracted and denounced in a public erratum.
It is important that all authors and organizations where the research has been carried out have consented to the work’s submission and that all authors have significantly contributed.
In order to establish transparency in research, authors should be sure to provide the following items.
1) Information regarding the source(s) of the work’s funding;
2) All financial and non-financial potential conflicts of interest;
3) A statement of informed consent for all studies that involve human participants;
4) A statements of human rights for all studies that involve human participants;
5) A statement on the humane treatment and proper welfare of all animals involved in the study.
The appropriate statements are provided below. They should be included in the Manuscript’s text in a section titled Ethical Compliance. This section should immediately precede the References section.
1) Sources of Funding
Please provide the names of all funding agencies, research grants, and grant numbers.
Statement
Source of Funding: This study was funded by ____________________.
2) Potential Conflicts of Interest
Authors are required to disclose all personal and professional relationships and interests that can be viewed as potentially imparting bias in the work. Readers are entitled to this information and to their own conclusions and perceptions of conflict. Potential conflicts could be financial relationships, employment, sponsorships, public holdings, competing interests, spousal interests, personal relationships, personal beliefs, etc.
Statement
a) Disclosure of Interest: The authors declare that they have no conflict of interest.
or
b) Disclosure of Interest:
3) Informed Consent
Study participants have the right to decide how the identifiable personal information gathered on them is used. It is essential that all participants (or guardians) give their written informed consent to participate in the study and its subsequent publication.
Statement
Informed consent was obtained from each individual participant involved in this study.
4) Statement of Human Rights
The wellbeing of human subjects takes precedence over the interests of science. If a study involves human participants, authors should include a statement that the study was conducted in accordance with the 1964 Declaration of Helsinki and its subsequent amendments.
Statement
This study was conducted in accordance with the 1964 Declaration of Helsinki and its subsequent amendments.
5) Statement of Animal Welfare
All studies that involve animals should contain a statement that the study and its procedures have been approved by their affiliate institutional research ethics committee.
Statement
All animals involved in this study were treated in accordance with the ethical standards set forth by the institution at which the study was conducted.
Committee on Publication Ethics
Nova and its editors follow the Codes of Conduct and Best Practice Guidelines set forth by the Committee on Publication Ethics (COPE). These codes and guidelines are valuable instructions that ensure transparency and fairness in research and publishing. The single document provides steps for submissions, peer-review, confidentiality, the creation and maintenance of editorial boards, editorial responsibilities and decision-making, communication policy, appeal procedures, handling complaints and instances of misconduct, quality assurance, publishing corrections and retractions, adherence to national and international ethics guidelines, and many more aspects of the publication process.
The COPE Codes of Conduct and Best Practice Guidelines can be read at the link below. We recommend your familiarity with them while you publish with Nova and any other scientific publisher.
https://publicationethics.org/resources/code-conduct
If you notice any ethical misconduct in Nova’s publications, please contact us.
Publisher’s Office
Nova Science Publishers, Inc.
415 Oser Avenue, Suite N
Hauppauge, New York 11788, USA
Phone: (631) 231-7269
E-mail: nova.main@novapublishers.com
Advertising Opportunities
Please contact our office using the information above.
